Up-regulation of Galectin-9 in vivo results in immunosuppressive effects and prolongs survival of liver allograft in rats

Immunology Letters

Volumn 162, Issue 1, 2014, Pages 217-222

  Liu, Yi Ming ^a   Chen, Yong ^a   Li, Jin Zheng ^a   Gong, Jian Ping ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Acute rejection response; Galectin 9; Induced immunosuppression; Orthotpoic liver transplantation

Indexed keywords

ADENOVIRUS VECTOR; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ECALECTIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; MESSENGER RNA; RETINOIC ACID RECEPTOR GAMMA; SODIUM CHLORIDE; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, RAT; GALECTIN; GALECTIN 9, RAT; RETINOID RELATED ORPHAN RECEPTOR GAMMA; T BOX TRANSCRIPTION FACTOR; T-BOX TRANSCRIPTION FACTOR TBX21;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLD ISCHEMIA; CONTROLLED STUDY; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; GRAFT SURVIVAL; IMMUNE DEFICIENCY; IN VIVO STUDY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; NONHUMAN; PLASMID; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; TH1 CELL; TH17 CELL; UPREGULATION; WESTERN BLOTTING; ANIMAL; BLOOD; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; GRAFT REJECTION; HELPER CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LIVER; METABOLISM; PATHOLOGY;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; FORKHEAD TRANSCRIPTION FACTORS; GALECTINS; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNE TOLERANCE; LIVER; LIVER TRANSPLANTATION; MALE; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; RATS; SURVIVAL RATE; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84908344274     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2014.09.002     Document Type: Article

References (19)

1. Starzl T.E., Fung J.J. Themes of liver transplantation. Hepatology 2010, 51(6):1869-1884.
2. Merion R.M. Current status and future of liver transplantation. Semin Liver Dis 2010, 30(4):411-421.
3. Wiesner R.H., Fung J.J. Present state of immunosuppressive therapy in liver transplant recipients. Liver Transpl 2011, 17:S1-S9.
4. Song A.T., Avelino-Silva V.I., Pecora R.A., Pugliese V., D'Albuquerque L.A., Abdala E. Liver transplantation: fifty years of experience. World J Gastroenterol 2014, 20(18):5363-5374.
5. Wood K.J., Goto R. Mechanisms of rejection: current perspectives. Transplantation 2012, 93(1):1-10.
6. Thomson A.W., Knolle P.A. Antigen-presenting cell function in the tolerogenic liver environment. Nat Rev Immunol 2010, 10(11):753-766.
7. Cedeno-Laurent F., Dimitroff C.J. Evidence of a novel galectin-9-binding membrane glycoprotein ligand on T helper cells. Clin Immunol 2012, 143(1):6-7.
8. Zhu C., Anderson A.C., Kuchroo V.K. TIM-3 and its regulatory role in immune responses. Curr Top Microbiol Immunol 2011, 350:1-15.
9. Carambia A1, Herkel J. CD4 T cells in hepatic immune tolerance. J Autoimmun 2010, 34(1):23-28.
10. Heidt S., Segundo D.S., Chadha R., Wood K.J. The impact of Th17 cells on transplant rejection and the induction of tolerance. Curr Opin Organ Transplant 2010, 15(4):456-461.
11. Peng Y., Gong J.P., Yan L.N., Li S.B., Li H Improved two-cuff technique for orthotopic liver transplantation in rat. Hepatobiliary Pancreat Dis Int 2004, 3(1):33-37.
12. Fung J.J., Bollinger J.E., Miller C., Eghtesad B. Future prospects in immunosuppression for liver transplantation. Liver Transpl 2011, 17(Suppl. 3):S54-S59.
13. Fändrich F. Tolerance in clinical transplantation: progress, challenge or just a dream?. Langenbecks Arch Surg 2011, 396:475-487.
14. Crispe I.N., Giannandrea M., Klein I., John B., Sampson B., Wuensch S. Cellular and molecular mechanisms of liver tolerance. Immunol Rev 2006, 213:101-118.
15. Liu Z., Fan H., Jiang S., He Y., Liu J., Gong J. CD4(+) T-cell subsets in transplantation. Immunol Rev 2013, 252(1):183-191.
16. Peng S.L. The T-box transcription factor T-bet in immunity and autoimmunity. Cell Mol Immunol 2006, 3(2):87-95.
17. Gupta S., Thornley T.B., Gao W., Larocca R., Turka L.A., Kuchroo V.K., et al. Allograft rejection is restrained by short-lived TIM-3+PD-1+Fxop3+ Tregs. J Clin Invest 2012, 122(7):2395-2404.
18. Li J., Lai X., Liao W., He Y., Liu Y., Cong J. The dynamic changes of Th17/Treg cytokines in rat liver transplant rejection and tolerance. Int Immunopharmacol 2011, 11(8):962-967.
19. Ashoor I.F., Najafian N. Rejection and regulation: a tight balance. Curr Opin Organ Transplant 2012, 17(1):1-7.